Onconetix, Inc. (ONCO)
2.30
-0.50
(-17.86%)
USD |
NASDAQ |
Dec 11, 16:00
2.30
0.00 (0.00%)
After-Hours: 17:32
Onconetix EPS Diluted (Quarterly): -6.250 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Veru, Inc. | -0.5003 |
| GT Biopharma, Inc. | -0.8268 |
| NovaBridge Biosciences | -0.0676 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.784M |
| Revenue (Quarterly) | 0.3037M |
| Total Expenses (Quarterly) | 9.087M |
| Enterprise Value | 0.7928M |
| Gross Profit Margin (Quarterly) | 88.54% |
| Profit Margin (Quarterly) | -2.89K% |
| Earnings Yield | -11.77K% |
| Normalized Earnings Yield | -4480.12 |